DK0398748T3 - NANBV-diagnostika: polynukleotider anvendelige til screening for hepatitis C virus - Google Patents
NANBV-diagnostika: polynukleotider anvendelige til screening for hepatitis C virusInfo
- Publication number
- DK0398748T3 DK0398748T3 DK90305421T DK90305421T DK0398748T3 DK 0398748 T3 DK0398748 T3 DK 0398748T3 DK 90305421 T DK90305421 T DK 90305421T DK 90305421 T DK90305421 T DK 90305421T DK 0398748 T3 DK0398748 T3 DK 0398748T3
- Authority
- DK
- Denmark
- Prior art keywords
- virus
- hepatitis
- screening
- polynucleotides useful
- hcv
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title abstract 5
- 102000040430 polynucleotide Human genes 0.000 title abstract 4
- 108091033319 polynucleotide Proteins 0.000 title abstract 4
- 239000002157 polynucleotide Substances 0.000 title abstract 4
- 238000012216 screening Methods 0.000 title 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 208000005176 Hepatitis C Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 208000010710 hepatitis C virus infection Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35596189A | 1989-05-18 | 1989-05-18 | |
| US45663789A | 1989-12-21 | 1989-12-21 | |
| US50543590A | 1990-04-04 | 1990-04-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0398748T3 true DK0398748T3 (da) | 2002-03-18 |
Family
ID=27408242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90305421T DK0398748T3 (da) | 1989-05-18 | 1990-05-18 | NANBV-diagnostika: polynukleotider anvendelige til screening for hepatitis C virus |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0398748B1 (fi) |
| JP (3) | JP2656996B2 (fi) |
| AT (1) | ATE211772T1 (fi) |
| AU (1) | AU638719B2 (fi) |
| BG (1) | BG60348B2 (fi) |
| CA (1) | CA2017157C (fi) |
| DE (1) | DE69033891T2 (fi) |
| DK (1) | DK0398748T3 (fi) |
| ES (1) | ES2166749T3 (fi) |
| FI (1) | FI105279B (fi) |
| GE (1) | GEP20002164B (fi) |
| HU (1) | HUT59964A (fi) |
| LV (1) | LV10729B (fi) |
| MC (1) | MC2188A1 (fi) |
| NO (1) | NO303503B1 (fi) |
| RO (1) | RO113059B1 (fi) |
| WO (1) | WO1990014436A1 (fi) |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6489246A (en) * | 1987-09-30 | 1989-04-03 | Sony Corp | Fixing method for color sorting mechanism of color cathode-ray tube |
| US5712088A (en) * | 1987-11-18 | 1998-01-27 | Chiron Corporation | Methods for detecting Hepatitis C virus using polynucleotides specific for same |
| US6861212B1 (en) | 1987-11-18 | 2005-03-01 | Chiron Corporation | NANBV diagnostics and vaccines |
| US5698390A (en) | 1987-11-18 | 1997-12-16 | Chiron Corporation | Hepatitis C immunoassays |
| US5714596A (en) * | 1987-11-18 | 1998-02-03 | Chiron Corporation | NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus |
| US6171782B1 (en) | 1987-11-18 | 2001-01-09 | Chiron Corporation | Antibody compositions to HCV and uses thereof |
| US6027729A (en) * | 1989-04-20 | 2000-02-22 | Chiron Corporation | NANBV Diagnostics and vaccines |
| US7166287B1 (en) | 1989-12-18 | 2007-01-23 | Glaxo Wellcome Inc. | Viral agent |
| FI906208A (fi) | 1989-12-18 | 1991-06-19 | Wellcome Found | Virala aemnen. |
| EP0461863A1 (en) * | 1990-06-12 | 1991-12-18 | Immuno Japan Inc. | Oligonucleotide primers, and their application for high-fidelity detection of non-A, non-B hepatitis virus |
| US5747339A (en) * | 1990-06-25 | 1998-05-05 | Research Foundation For Microbial Diseases Of Osaka | Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide |
| WO1992000328A1 (en) * | 1990-06-30 | 1992-01-09 | Akzo N.V. | Non-a non-b sequences |
| ES2100185T3 (es) * | 1990-07-11 | 1997-06-16 | Shionogi & Co | Secuencia de adnc y deteccion del virus de la hepatitis c. |
| WO1992001714A1 (en) * | 1990-07-24 | 1992-02-06 | Yamanouchi Pharmaceutical Co., Ltd. | Non-a non-b hepatitis virus antigen |
| HU227499B1 (en) * | 1990-08-10 | 2011-07-28 | Novartis Vaccines & Diagnostic | Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus |
| KR920703640A (ko) * | 1990-11-29 | 1992-12-18 | 테루카츄 아리마 | 비a비b형 간염 바이러스 항원 단백질 |
| EP0571554A1 (en) * | 1991-01-14 | 1993-12-01 | James N. Gamble Institute Of Medical Research | Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods |
| ATE112782T1 (de) * | 1991-03-01 | 1994-10-15 | Akzo Nobel Nv | Mit antikörper gegen hepatitis non-a, non-b-virus immunochemische reaktive peptide. |
| US5574132A (en) * | 1991-04-05 | 1996-11-12 | Biochem Immunosystems Inc. | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) |
| EP0510952A1 (en) * | 1991-04-26 | 1992-10-28 | Immuno Japan Inc. | Oligonucleotide primers and their application for high-fidelity detection of non-a, non-b hepatitis virus |
| FR2677372B1 (fr) * | 1991-06-06 | 1994-11-10 | Pasteur Institut | Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques. |
| IT1249684B (it) * | 1991-07-19 | 1995-03-09 | Sorin Biomedica Spa | Epitopi della proteina env del virus dell'epatite c. |
| ATE241704T1 (de) * | 1991-08-27 | 2003-06-15 | Hoffmann La Roche | Primers und sondern zum nachweis von hepatitis c |
| WO1993005181A1 (en) * | 1991-09-12 | 1993-03-18 | Cedars-Sinai Medical Center | Direct detection of hepatitis c virus rna |
| DK0608261T3 (da) | 1991-09-13 | 2003-03-17 | Chiron Corp | Sammensætninger med immunreaktivt hepatitis C virus polypeptid |
| CA2099883A1 (en) * | 1991-11-07 | 1993-05-08 | John A. Kink | Epitope mapping of the c33c region of hcv |
| DE610436T1 (de) * | 1991-11-21 | 1995-08-03 | Common Services Agency | Detektion des Hepatis-C Virus. |
| GB9204274D0 (en) * | 1992-02-28 | 1992-04-08 | Wellcome Found | Novel peptides |
| US5866139A (en) * | 1992-06-04 | 1999-02-02 | Institut Pasteur | Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications |
| US6057093A (en) * | 1992-09-28 | 2000-05-02 | Chiron Corporation | Methods and compositions for controlling translation of HCV proteins |
| JPH06153961A (ja) * | 1992-11-27 | 1994-06-03 | Imuno Japan:Kk | Ｃ型肝炎ウイルス部分遺伝子、ならびにｃ型肝炎ウイルス遺 伝子の高感度検出法 |
| DE69433160T2 (de) | 1993-05-12 | 2004-07-08 | Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville | Konserviertes Motiv der Hepatitis C Virus E2/NS1 Region |
| EP1510580B1 (en) | 1994-07-29 | 2008-12-10 | Novartis Vaccines and Diagnostics, Inc. | Hepatitis C E2 truncated polypeptide and methods of obtaining the same |
| AU3241095A (en) * | 1994-07-29 | 1996-03-04 | Chiron Corporation | Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
| US5837442A (en) | 1995-11-29 | 1998-11-17 | Roche Molecular Systems, Inc. | Oligonucleotide primers for amplifying HCV nucleic acid |
| JP4458556B2 (ja) | 1997-05-06 | 2010-04-28 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | Ｃ型肝炎のｅ２短縮型ポリペプチドの細胞内生成 |
| DE19832050C2 (de) * | 1998-07-16 | 2002-10-10 | Biotest Pharma Gmbh | Verfahren zum Nachweis von Hepatitis B- bzw. Hepatitis C-Virusgenomen in Plasmaproben und spezifische Primer |
| CA2366688A1 (en) | 1999-02-26 | 2000-08-31 | Chiron Corporation | Use of bioadhesives and adjuvants for the mucosal delivery of antigens |
| US8206749B1 (en) | 1999-02-26 | 2012-06-26 | Novartis Vaccines And Diagnostics, Inc. | Microemulsions with adsorbed macromolecules and microparticles |
| US7196066B1 (en) | 1999-11-03 | 2007-03-27 | Powderject Vaccines, Inc. | DNA-vaccines based on constructs derived from the genomes of human and animal pathogens |
| DE60129598T2 (de) * | 2000-06-15 | 2008-04-17 | Novartis Vaccines and Diagnostics, Inc., Emeryville | Immunoassays für anti-hcv-antikörper |
| KR100801123B1 (ko) | 2000-08-17 | 2008-02-05 | 트리펩 아베 | 리바비린 함유 백신 및 이것의 사용 방법 |
| US6680059B2 (en) | 2000-08-29 | 2004-01-20 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
| US6858590B2 (en) | 2000-08-17 | 2005-02-22 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
| US7022830B2 (en) | 2000-08-17 | 2006-04-04 | Tripep Ab | Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| US6586584B2 (en) | 2001-01-29 | 2003-07-01 | Becton, Dickinson And Company | Sequences and methods for detection of Hepatitis C virus |
| EP1399183B1 (en) | 2001-05-31 | 2010-06-30 | Novartis Vaccines and Diagnostics, Inc. | Chimeric alphavirus replicon particles |
| AR045702A1 (es) | 2001-10-03 | 2005-11-09 | Chiron Corp | Composiciones de adyuvantes. |
| JP4646516B2 (ja) | 2002-02-20 | 2011-03-09 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | 吸着したポリペプチド含有分子を有する微粒子 |
| US7598421B2 (en) | 2002-05-08 | 2009-10-06 | Ucl Biomedica Plc | Materials for the delivery of biologically-active material to cells |
| US8034378B2 (en) | 2002-12-27 | 2011-10-11 | Novartis Vaccines And Diagnostics, Inc | Immunogenic compositions containing phospholipid |
| WO2004084936A2 (en) | 2003-02-06 | 2004-10-07 | Cerus Corporation | Modified free-living microbes, vaccine compositions and methods of use thereof |
| US7695725B2 (en) | 2003-02-06 | 2010-04-13 | Aduro Biotech | Modified free-living microbes, vaccine compositions and methods of use thereof |
| CA2515369C (en) | 2003-02-06 | 2015-03-31 | Cerus Corporation | Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof |
| US7731967B2 (en) | 2003-04-30 | 2010-06-08 | Novartis Vaccines And Diagnostics, Inc. | Compositions for inducing immune responses |
| US7842289B2 (en) | 2003-12-24 | 2010-11-30 | Aduro Biotech | Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof |
| WO2006078318A2 (en) | 2004-07-29 | 2006-07-27 | Novartis Vaccines And Diagnostics Inc. | Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
| EP1802778B1 (en) | 2004-08-27 | 2011-10-05 | Novartis Vaccines and Diagnostics, Inc. | Hcv multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof |
| WO2007031867A2 (en) | 2005-05-25 | 2007-03-22 | Tripep Ab | A hepatitis c virus non-stru tural ns3/4a fusion gene |
| EP2527474A1 (en) * | 2006-10-20 | 2012-11-28 | Innogenetics N.V. | Methodology for analysis of sequence variations within the HCV NS3/4A genomic region |
| WO2009022236A2 (en) | 2007-08-16 | 2009-02-19 | Tripep Ab | Immunogen platform |
| ES2664753T3 (es) | 2007-12-07 | 2018-04-23 | Glaxosmithkline Biologicals Sa | Composiciones de inducción de respuestas inmunes |
| WO2009130588A2 (en) | 2008-04-22 | 2009-10-29 | Tripep Ab | Immunogen platform |
| AU2009249273A1 (en) | 2008-05-19 | 2009-11-26 | Aduro Biotech | Compositions comprising PrfA*mutant listeria and methods of use thereof |
| KR20120022760A (ko) | 2009-03-09 | 2012-03-12 | 윌리엄 헨리 | 담체로서 시그널 펩티드를 가지는 박테리아 독소를 포함하는 햅텐-담체 접합체와 면역원성 조성물에 있어서 이의 용도 |
| FI122954B (fi) | 2011-01-31 | 2012-09-14 | Teknoware Oy | LED-putkilamppu ja valaisinjärjestely |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| CN1049686C (zh) * | 1987-11-18 | 2000-02-23 | 希龙股份有限公司 | 非ａ和非ｂ肝炎病毒的诊断及疫苗 |
| US5191064A (en) * | 1988-09-30 | 1993-03-02 | The Research Foundation For Microbial Diseases (Osaka University) | Non-a, non-b hepatitis virus antigen peptide |
| UA50829C2 (uk) * | 1989-03-17 | 2002-11-15 | Чірон Корпорейшн | Очищений поліпептид, що містить антиген вірусу гепатиту с, полінуклеотид, вектор, клітини, система експресії, моноклональне антитіло, препарат поліклональних антитіл, нуклеотидна проба, аналітичні набори, спосіб виявлення нуклеїнових кислот, способи імуноаналізу, вакцина, спосіб одержання антитіл |
| AU638304B2 (en) * | 1989-12-22 | 1993-06-24 | Abbott Laboratories | Hepatitis c assay |
| EP0527786A1 (en) * | 1990-04-03 | 1993-02-24 | Southwest Foundation For Biomedical Research | Purified hcv and hcv proteins and peptides |
-
1990
- 1990-05-18 AT AT90305421T patent/ATE211772T1/de not_active IP Right Cessation
- 1990-05-18 RO RO149205A patent/RO113059B1/ro unknown
- 1990-05-18 CA CA002017157A patent/CA2017157C/en not_active Expired - Lifetime
- 1990-05-18 EP EP90305421A patent/EP0398748B1/en not_active Expired - Lifetime
- 1990-05-18 DE DE69033891T patent/DE69033891T2/de not_active Expired - Lifetime
- 1990-05-18 DK DK90305421T patent/DK0398748T3/da active
- 1990-05-18 AU AU58123/90A patent/AU638719B2/en not_active Expired
- 1990-05-18 MC MC@@@@@@@@@@@@D patent/MC2188A1/xx unknown
- 1990-05-18 HU HU904754A patent/HUT59964A/hu unknown
- 1990-05-18 ES ES90305421T patent/ES2166749T3/es not_active Expired - Lifetime
- 1990-05-18 GE GE1876A patent/GEP20002164B/en unknown
- 1990-05-18 JP JP2508534A patent/JP2656996B2/ja not_active Expired - Lifetime
- 1990-05-18 WO PCT/US1990/002853 patent/WO1990014436A1/en active IP Right Grant
-
1991
- 1991-11-18 BG BG95495A patent/BG60348B2/bg unknown
- 1991-11-18 FI FI915443A patent/FI105279B/fi active
- 1991-11-18 NO NO914517A patent/NO303503B1/no not_active IP Right Cessation
-
1993
- 1993-06-01 LV LVP-93-456A patent/LV10729B/en unknown
-
1996
- 1996-10-30 JP JP30570796A patent/JP3701754B2/ja not_active Expired - Lifetime
-
1997
- 1997-05-19 JP JP14598597A patent/JP3698520B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2656996B2 (ja) | 1997-09-24 |
| LV10729B (en) | 1995-12-20 |
| JPH1089A (ja) | 1998-01-06 |
| MC2188A1 (fr) | 1992-09-16 |
| GEP20002164B (en) | 2000-07-10 |
| HUT59964A (en) | 1992-07-28 |
| ES2166749T3 (es) | 2002-05-01 |
| FI915443A0 (fi) | 1991-11-18 |
| LV10729A (lv) | 1995-06-20 |
| CA2017157A1 (en) | 1990-11-18 |
| JPH10113176A (ja) | 1998-05-06 |
| JPH05500155A (ja) | 1993-01-21 |
| DE69033891D1 (de) | 2002-02-21 |
| RO113059B1 (ro) | 1998-03-30 |
| EP0398748B1 (en) | 2002-01-09 |
| EP0398748A3 (en) | 1991-10-23 |
| HU904754D0 (en) | 1992-01-28 |
| NO914517L (no) | 1992-01-16 |
| JP3701754B2 (ja) | 2005-10-05 |
| DE69033891T2 (de) | 2002-08-29 |
| CA2017157C (en) | 2003-07-29 |
| WO1990014436A1 (en) | 1990-11-29 |
| ATE211772T1 (de) | 2002-01-15 |
| NO303503B1 (no) | 1998-07-20 |
| AU638719B2 (en) | 1993-07-08 |
| BG60348B2 (bg) | 1994-09-30 |
| FI105279B (fi) | 2000-07-14 |
| EP0398748A2 (en) | 1990-11-22 |
| AU5812390A (en) | 1990-12-18 |
| JP3698520B2 (ja) | 2005-09-21 |
| NO914517D0 (no) | 1991-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0398748T3 (da) | NANBV-diagnostika: polynukleotider anvendelige til screening for hepatitis C virus | |
| DK0543924T3 (da) | NANBV-diagnostik: polynucleotider, som er anvendelige til screening for hepatitis C-virus | |
| ATE507312T1 (de) | Nachweis und typisierung das hepatitis c virus (hcv) mittels 5'utr und ns5 nukleinsäuresequenzen | |
| ES2176342T3 (es) | Secuencias del genotipo 7 del virus de la hepatitis c y su utilizacioncomo agentes profilacticos, terapeuticos y de diagnostico. | |
| DE69839557D1 (de) | Klonierte genome von infektiösen hepatitis c viren und deren verwendungen | |
| ATE373093T1 (de) | Sequenzen der genotype des hepatitis-c-virus sowie ihre verwendung als arzneimitteln und diagnostika | |
| HUT53148A (en) | Process for producing vaccines against contamination by non-a, non-b hepatitis virus and diagnostics suitable for detecting contamination | |
| DK0484787T3 (da) | HCV-specifikke peptider, fremgangsmåde til opnåelse deraf og anvendelse deraf | |
| CA2108466A1 (en) | Hcv genomic sequences for diagnostics and therapeutics | |
| FI955224A0 (fi) | Hepatiitti-C-virustyypit 4,5 ja 6 | |
| ATE90073T1 (de) | Verfahren zur herstellung von n-acyl-anilinen. | |
| JPS53119838A (en) | Improved preparation of resorcins |